| SHORT COMMUNICATION |
|
| Year : 2014 | Volume
: 5
| Issue : 2 | Page : 193-194 |
|
|
Utility of pre-treatment evaluation in Initiation of multi-drug resistant tuberculosis treatment
Saurabh RamBihariLal Shrivastava, Prateek Saurabh Shrivastava, Jegadeesh Ramasamy
Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, Kancheepuram, Tamil Nadu, India
Correspondence Address:
Saurabh RamBihariLal Shrivastava
3rd floor, Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, Ammapettai Village, Thiruporur-Guduvancherry Main Road, Sembakkam Post, Kancheepuram - 603 108, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0975-9727.135788
|
|
|
The emergence of resistance to the first line anti-tuberculosis) drugs has posed a significant threat to the global mission of reducing the magnitude of TB. Considering the life threatening nature of the multi-drug resistant TB (MDR-TB), in addition to the poor cure rate or success rate, high default rate or incidence of complications and the potential risk of transmission of the disease to a susceptible contact, early diagnosis and initiation of the patient on second-line anti-TB drugs is of prime public health importance. The first step in ensuring a good outcome is to initiate the MDR-TB treatment regimen based on the pre-treatment evaluation (PTE) done at the drug resistant TB (DR-TB) center by an expert committee. To conclude, PTE is the crucial foundation in ensuring a favorable outcome to the treatment of DR-TB as a good PTE can detect and avert the possible drug induced adverse effects at the earliest. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
